当前位置：
X-MOL 学术
›
Ann. Lab. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence Studies.
Annals of Laboratory Medicine ( IF 4.0 ) Pub Date : 2021-8-11 , DOI: 10.3343/alm.2022.42.1.71 Younhee Park 1 , Ki Ho Hong 1 , Su-Kyung Lee 2 , Jungwon Hyun 2 , Eun-Jee Oh 3 , Jaehyeon Lee 4 , Hyukmin Lee 1 , Sang Hoon Song 5 , Seung-Jung Kee 6 , Gye Cheol Kwon 7 , Su Hwan Kim 8 , Hyeon-Nam Do 8 , Ah-Ra Kim 8 , June-Woo Lee 8 , Sung Soon Kim 8 , Hyun Soo Kim 2
Annals of Laboratory Medicine ( IF 4.0 ) Pub Date : 2021-8-11 , DOI: 10.3343/alm.2022.42.1.71 Younhee Park 1 , Ki Ho Hong 1 , Su-Kyung Lee 2 , Jungwon Hyun 2 , Eun-Jee Oh 3 , Jaehyeon Lee 4 , Hyukmin Lee 1 , Sang Hoon Song 5 , Seung-Jung Kee 6 , Gye Cheol Kwon 7 , Su Hwan Kim 8 , Hyeon-Nam Do 8 , Ah-Ra Kim 8 , June-Woo Lee 8 , Sung Soon Kim 8 , Hyun Soo Kim 2
Affiliation
Seroprevalence studies of coronavirus disease 2019 (COVID-19) cases, including asymptomatic and past infections, are important to estimate the scale of the disease outbreak and to establish quarantine measures. We evaluated the clinical performance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assays available in Korea for use in seroprevalence studies.
中文翻译：
用于血清阳性率研究的五种 SARS-CoV-2 抗体检测的性能比较。
对 2019 年冠状病毒病 (COVID-19) 病例（包括无症状感染和既往感染）的血清阳性率研究对于估计疾病爆发的规模和制定隔离措施非常重要。我们评估了韩国可用于血清阳性率研究的严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 抗体检测的临床表现。
更新日期：2021-08-11
中文翻译：
用于血清阳性率研究的五种 SARS-CoV-2 抗体检测的性能比较。
对 2019 年冠状病毒病 (COVID-19) 病例（包括无症状感染和既往感染）的血清阳性率研究对于估计疾病爆发的规模和制定隔离措施非常重要。我们评估了韩国可用于血清阳性率研究的严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 抗体检测的临床表现。
京公网安备 11010802027423号